生物材料市场 - 分产品（金属、聚合物、陶瓷、天然）、按应用（心血管、骨科、牙科、整形外科、眼科、伤口癒合、神经病学、组织工程）及预测，2023 - 2032

Biomaterials Market - By Product (Metallic, Polymeric, Ceramic, Natural), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Ophthalmology, Wound Healing, Neurology, Tissue Engineering) & Forecast, 2023 - 2032

出版日期: 2023年08月31日 | 出版商:

Global Market Insights Inc. | 英文 485 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年至 2032 年间，全球生物材料市场复合年增长率将超过 12.6%。有前途的新创公司和创新品牌不断增加的投资正在推动市场成长。例如，2023 年 10 月，专门从事生物材料的新创公司 GOZEN 获得了 330 万美元的种子资金，该公司有望彻底改变时尚、汽车和家居产业。本轮融资由 Happiness Capital 牵头，将使 GOZEN 能够加快其创新生物材料 LUNAFORM (TM) 的研究、开发和规模化计画。此外，它将提供开创新型先进材料创造所需的资源。

这些新进入者正在为该行业注入新颖的想法和突破性的技术。这种创造力和资本的注入正在推动尖端生物材料的发展。因此，随着该行业不断发展以满足医疗保健、製造等各个行业的需求，生物材料市场前景必将增强。

整个生物材料市场根据产品、应用和地区进行分类。

高分子生物材料领域将在 2023 年至 2032 年间经历重大发展。这些多功能材料在从植入物到药物传输系统的各种医疗应用中发挥关键作用。它们的生物相容性、可调特性和低免疫原性使它们对医疗和保健行业越来越有吸引力。随着聚合物生物材料研究和开发的进步，该领域的生物材料市场规模将继续其成长轨迹。

2023年至2032年，眼科领域的复合年增长率将显着。这一增长归因于用于人工晶状体、角膜植入物和药物输送系统的先进生物材料的开发。眼科生物材料因其生物相容性和更精确地解决视觉相关问题的能力而受到追捧。随着眼睛健康的重要性日益增加，眼科生物材料市场需求也随之增加。

2023年至2032年，欧洲生物材料市场将呈现可观的复合年增长率。对生物可降解聚合物、组织工程支架和生物活性陶瓷等生物材料的需求正在上升。欧洲对环保解决方案和医疗技术进步的坚定承诺正在推动生物材料在从医疗设备到再生医学等多种应用中的采用，使该地区成为该市场的关键参与者。例如，2023 年 10 月，专门开发源自伦敦海藻的生物塑胶材料的蓝色生物技术公司 FlexSea 在种子轮融资中成功获得 230 万欧元的股权融资。

产业生态系统分析
产业影响力
- 成长动力
  - 医疗应用对生物相容性和可生物降解材料的需求不断增加
  - 组织工程日益普及
  - 奈米技术和组织工程的进展
  - 政府推动生物材料产品使用的倡议
- 产业陷阱与挑战
  - 生物材料开发成本高
  - 生物相容性和安全问题
成长潜力分析
COVID-19 影响分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：生物材料市场规模与预测：依产品分类，2018 - 2032

主要动向：按产品
金属生物材料
- 钛及钛合金
- 不銹钢
- 银
- 钴铬合金
- 金子
- 镁
高分子生物材料
- 聚酯纤维
- 硅橡胶
- 聚乙烯
- 聚甲基丙烯酸甲酯
- 聚醚醚酮
- 尼龙
- 其他高分子生物材料
陶瓷生物材料
- 磷酸钙
- 氧化锆
- 硫酸钙
- 碳
- 氧化铝
- 玻璃
天然生物材料
- 玻尿酸
- 胶原
- 丝绸
- 海藻酸盐
- 纤维蛋白
- 明胶
- 纤维素
- 甲壳质

第 6 章：生物材料市场规模与预测：按应用，2018 - 2032

主要动向：按应用
心血管
- 植入式心臟去颤器
- 起搏器
- 支架
- 血管移植物
- 感应器
- 导丝
- 其他心血管应用
眼科
- 隐形眼镜
- 人工水晶体
- 眼组织置换
- 人工角膜
- 其他眼科应用
牙科
- 植牙
- 组织再生材料
- 骨移植和替代品
- 牙膜
- 其他牙科应用
骨科
- 关节置换生物材料
- 骨科生物製剂
- 生物可吸收组织固定产品
- 黏性补充
- 脊椎生物材料
- 其他骨科应用
伤口癒合
- 骨折癒合装置
- 黏附屏障
- 皮肤替代品
- 内部组织密封剂
- 手术止血钳
- 其他伤口癒合应用
整型手术
- 软组织填充剂
- 脸部皱纹治疗
- 颅颜手术
- 生物工程皮肤
- 週边神经修復
- 无细胞真皮基质
- 其他整形外科应用
神经病学
- 神经干细胞封装
- 调车系统
- 用于中枢神经系统修復的水凝胶支架
- 皮质神经假体
- 其他神经学应用
组织工程
其他应用

第 7 章：生物材料市场规模与预测：按地区划分，2018 - 2032

主要动向：按地区
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 8 章：公司简介

BASF SE
Covestro AG
ROYAL DSM
Celanese Corporation
Carpenter Technology Corporation
Corbion
EVONIK INDUSTRIES
Berkeley Advanced Biomaterials
CAM Bioceramics B.V.
CeramTec GmbH
Noble Biomaterials
Victrex plc.
Mitsubishi Chemical Group Corporation.
CoorsTek Inc.
Zeus Company Inc.

简介目录

Product Code: 6603

Global Biomaterials Market will witness over 12.6% CAGR between 2023 and 2032. Increasing investments from promising startups and innovative brands are leading to market growth. For instance, in October 2023, GOZEN, a startup specializing in biomaterials poised to revolutionize the fashion, automotive, and home furnishings sectors, secured $3.3 million in seed funding. This funding round, spearheaded by Happiness Capital, will empower GOZEN to expedite its research, development, and scaling initiatives for its innovative biomaterial, LUNAFORM™. Additionally, it will provide the resources needed to pioneer the creation of new, advanced materials.

These fresh entrants are infusing the industry with novel ideas and groundbreaking technologies. This injection of creativity and capital is driving the development of cutting-edge biomaterials. Therefore, as the industry evolves to meet the demands of various sectors, including healthcare, manufacturing, and beyond, the biomaterials market outlook is set to strengthen.

The overall Biomaterials Market is classified based on product, application, and region.

Polymeric biomaterials segment will undergo significant development from 2023 to 2032. These versatile materials play a pivotal role in various medical applications, from implants to drug delivery systems. Their biocompatibility, tunable properties, and low immunogenicity make them increasingly attractive to medical and healthcare industries. As research and development in polymeric biomaterials advance, the biomaterials market size from this segment is set to continue its growth trajectory.

Ophthalmology segment will register a notable CAGR from 2023 to 2032. This surge is attributed to the development of advanced biomaterials for intraocular lenses, corneal implants, and drug delivery systems. Ophthalmic biomaterials are sought after for their biocompatibility and ability to address vision-related issues with greater precision. As the importance of eye health grows, so does the biomaterials market demand in ophthalmology.

Europe biomaterials market will showcase an appreciable CAGR from 2023 to 2032. Demand for biomaterials, such as biodegradable polymers, tissue engineering scaffolds, and bioactive ceramics, is on the rise. Europe's strong commitment to eco-friendly solutions and advancements in medical technologies is driving the adoption of biomaterials across diverse applications, from medical devices to regenerative medicine, positioning the region as a key player in this market. For instance, in October 2023, FlexSea, a blue biotech firm specializing in the development of bioplastic materials derived from seaweed originating from London, successfully secured €2.3 million in equity funding during its seed round.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis
1.5 Data validation
1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Biomaterials industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Application trends

Chapter 3 Biomaterials Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing demand for biocompatible and biodegradable materials in medical applications
  - 3.2.1.2 Growing popularity of tissue engineering
  - 3.2.1.3 Advances in nanotechnology and tissue engineering
  - 3.2.1.4 Government initiatives to promote the use of biomaterial products
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High development cost for biomaterials
  - 3.2.2.2 Biocompatibility and safety concerns
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
3.4 COVID- 19 impact analysis
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022

Chapter 5 Biomaterials Market Size and Forecast, By Product, 2018 - 2032 (USD Million)

5.1 Key trends, by product
5.2 Metallic biomaterials
- 5.2.1 Titanium & titanium alloys
- 5.2.2 Stainless steel
- 5.2.3 Silver
- 5.2.4 Cobalt-chrome alloys
- 5.2.5 Gold
- 5.2.6 Magnesium
5.3 Polymeric biomaterials
- 5.3.1 Polyester
- 5.3.2 Silicone rubber
- 5.3.3 Polyethylene
- 5.3.4 Polymethymethacrylate
- 5.3.5 Polyetheretherketone
- 5.3.6 Nylon
- 5.3.7 Other polymeric biomaterials
5.4 Ceramic biomaterials
- 5.4.1 Calcium phosphate
- 5.4.2 Zirconia
- 5.4.3 Calcium sulfate
- 5.4.4 Carbon
- 5.4.5 Aluminium oxide
- 5.4.6 Glass
5.5 Natural biomaterials
- 5.5.1 Hyaluronic acid
- 5.5.2 Collagen
- 5.5.3 Silk
- 5.5.4 Alginates
- 5.5.5 Fibrin
- 5.5.6 Gelatin
- 5.5.7 Cellulose
- 5.5.8 Chitin

Chapter 6 Biomaterials Market Size and Forecast, By Application, 2018 - 2032 (USD Million)

6.1 Key trends, by application
6.2 Cardiovascular
- 6.2.1 Implantable cardiac defibrillators
- 6.2.2 Pacemakers
- 6.2.3 Stents
- 6.2.4 Vascular grafts
- 6.2.5 Sensors
- 6.2.6 Guidewires
- 6.2.7 Other cardiovascular applications
6.3 Ophthalmology
- 6.3.1 Contact lens
- 6.3.2 Intraocular lens
- 6.3.3 Ocular tissue replacement
- 6.3.4 Synthetic corneas
- 6.3.5 Other ophthalmic applications
6.4 Dental
- 6.4.1 Dental implants
- 6.4.2 Tissue regeneration materials
- 6.4.3 Bone grafts & substitutes
- 6.4.4 Dental membranes
- 6.4.5 Other dental applications
6.5 Orthopedic
- 6.5.1 Joint replacement biomaterials
- 6.5.2 Orthobiologics
- 6.5.3 Bioresorbable tissue fixation products
- 6.5.4 Visco supplementation
- 6.5.5 Spine biomaterials
- 6.5.6 Other orthopedic applications
6.6 Wound healing
- 6.6.1 Fracture healing device
- 6.6.2 Adhesion barrier
- 6.6.3 Skin substitutes
- 6.6.4 Internal tissue sealant
- 6.6.5 Surgical hemostats
- 6.6.6 Other wound healing applications
6.7 Plastic surgery
- 6.7.1 Soft tissue fillers
- 6.7.2 Facial wrinkle treatment
- 6.7.3 Craniofacial surgery
- 6.7.4 Bioengineered skins
- 6.7.5 Peripheral nerve repair
- 6.7.6 Acellular dermal matrices
- 6.7.7 Other plastic surgery applications
6.8 Neurology
- 6.8.1 Neural stem cell encapsulation
- 6.8.2 Shunting systems
- 6.8.3 Hydrogel scaffold for CNS repair
- 6.8.4 Cortical neural prosthetics
- 6.8.5 Other neurology applications
6.9 Tissue engineering
6.10 Other applications

Chapter 7 Biomaterials Market Size and Forecast, By Region, 2018 - 2032 (USD Million)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
7.6 Middle East & Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 Rest of Middle East & Africa